Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.

Coats CJ, Masri A, Nassif ME, Barriales-Villa R, Arad M, Cardim N, Choudhury L, Claggett B, Düngen HD, Garcia-Pavia P, Hagège AA, Januzzi JL, Lee MMY, Lewis GD, Ma CS, Maron MS, Miao ZM, Michels M, Olivotto I, Oreziak A, Owens AT, Spertus JA, Solomon SD, Tfelt-Hansen J, van Sinttruije M, Veselka J, Watkins H, Jacoby DL, German P, Heitner SB, Kupfer S, Lutz JD, Malik FI, Meng L, Wohltman A, Abraham TP, SEQUOIA‐HCM Investigators *.

Open source

DOI: 10.1161/jaha.124.035993
Published: 2024-07-26
Container: J Am Heart Assoc
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1161/jaha.124.035993,
  title = {Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.},
  author = {Coats CJ and  Masri A and  Nassif ME and  Barriales-Villa R and  Arad M and  Cardim N and  Choudhury L and  Claggett B and  Düngen HD and  Garcia-Pavia P and  Hagège AA and  Januzzi JL and  Lee MMY and  Lewis GD and  Ma CS and  Maron MS and  Miao ZM and  Michels M and  Olivotto I and  Oreziak A and  Owens AT and  Spertus JA and  Solomon SD and  Tfelt-Hansen J and  van Sinttruije M and  Veselka J and  Watkins H and  Jacoby DL and  German P and  Heitner SB and  Kupfer S and  Lutz JD and  Malik FI and  Meng L and  Wohltman A and  Abraham TP and  SEQUOIA‐HCM Investigators *.},
  year = {2024},
  journal = {J Am Heart Assoc},
  doi = {10.1161/jaha.124.035993},
  url = {https://doi.org/10.1161/jaha.124.035993}
}

RIS

TY  - JOUR
TI  - Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.
AU  - Coats CJ
AU  -  Masri A
AU  -  Nassif ME
AU  -  Barriales-Villa R
AU  -  Arad M
AU  -  Cardim N
AU  -  Choudhury L
AU  -  Claggett B
AU  -  Düngen HD
AU  -  Garcia-Pavia P
AU  -  Hagège AA
AU  -  Januzzi JL
AU  -  Lee MMY
AU  -  Lewis GD
AU  -  Ma CS
AU  -  Maron MS
AU  -  Miao ZM
AU  -  Michels M
AU  -  Olivotto I
AU  -  Oreziak A
AU  -  Owens AT
AU  -  Spertus JA
AU  -  Solomon SD
AU  -  Tfelt-Hansen J
AU  -  van Sinttruije M
AU  -  Veselka J
AU  -  Watkins H
AU  -  Jacoby DL
AU  -  German P
AU  -  Heitner SB
AU  -  Kupfer S
AU  -  Lutz JD
AU  -  Malik FI
AU  -  Meng L
AU  -  Wohltman A
AU  -  Abraham TP
AU  -  SEQUOIA‐HCM Investigators *.
PY  - 2024
JO  - J Am Heart Assoc
DO  - 10.1161/jaha.124.035993
UR  - https://doi.org/10.1161/jaha.124.035993
ER  -

APA

CJ, C., A, M., ME, N., R, B., M, A., N, C., L, C., B, C., HD, D., P, G., AA, H., JL, J., MMY, L., GD, L., CS, M., MS, M., ZM, M., M, M., I, O., A, O., AT, O., JA, S., SD, S., J, T., M, V. S., J, V., H, W., DL, J., P, G., SB, H., S, K., JD, L., FI, M., L, M., A, W., TP, A., & *., S. I. (2024). Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.. J Am Heart Assoc. https://doi.org/10.1161/jaha.124.035993

Source records

europe-pmc · retrieved 2026-09-26T18:38:01.832Z
doaj · retrieved 2026-09-26T18:38:01.835Z